APO Research
Talk to an analyst

APO RESEARCH · REPORT

Optical Genome Mapping Technology

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Optical Genome Mapping Technology Market Outlook and Growth Opportunities 2026

22 January 2026192 pages

Choose your research edition.

Industry ResearchOptical Genome Mapping Technology Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Optical Genome Mapping Technology Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Optical Genome Mapping Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Optical Genome Mapping Technology Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Optical Genome Mapping Technology Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Optical Genome Mapping Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Optical Genome Mapping Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Optical Genome Mapping Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Optical Genome Mapping Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Optical Genome Mapping Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Optical Genome Mapping Technology market include Bionano Genomics, PerkinElmer, Nabsys, Praxis Genomics, France Génomique, Nucleome Informatics and OpGen, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Optical Genome Mapping Technology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Optical Genome Mapping Technology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Optical Genome Mapping Technology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Optical Genome Mapping Technology market.

Optical Genome Mapping Technology Segment by Company

Bionano Genomics

PerkinElmer

Nabsys

Praxis Genomics

France Génomique

Nucleome Informatics

OpGen

Optical Genome Mapping Technology Segment by Type

Instrument

System

Service

Optical Genome Mapping Technology Segment by Application

Biotechnology and Pharmaceutical Companies

Clinical Laboratory

Academic Institution

Others

Optical Genome Mapping Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Optical Genome Mapping Technology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Optical Genome Mapping Technology key companies, revenue, market share, and recent developments.

3. To split the Optical Genome Mapping Technology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Optical Genome Mapping Technology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Optical Genome Mapping Technology significant trends, drivers, influence factors in global and regions.

6. To analyze Optical Genome Mapping Technology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Optical Genome Mapping Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Optical Genome Mapping Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Optical Genome Mapping Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Optical Genome Mapping Technology industry.

Chapter 3: Detailed analysis of Optical Genome Mapping Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Optical Genome Mapping Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Optical Genome Mapping Technology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Optical Genome Mapping Technology Industry Trends Table 2. Optical Genome Mapping Technology Industry Drivers Table 3. Optical Genome Mapping Technology Industry Opportunities and Challenges Table 4. Optical Genome Mapping Technology Industry Restraints Table 5. Global Optical Genome Mapping Technology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Optical Genome Mapping Technology Revenue Share by Company (2021-2026) Table 7. Global Optical Genome Mapping Technology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Optical Genome Mapping Technology Key Company Manufacturing Base & Headquarters Table 9. Global Optical Genome Mapping Technology Company, Product Type & Application Table 10. Global Optical Genome Mapping Technology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Optical Genome Mapping Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Instrument Table 15. Significant Companies of System Table 16. Significant Companies of Service Table 17. Global Optical Genome Mapping Technology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Optical Genome Mapping Technology Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Optical Genome Mapping Technology Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Optical Genome Mapping Technology Sales Value Share by Type (2021-2026) Table 21. Global Optical Genome Mapping Technology Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Biotechnology and Pharmaceutical Companies Table 23. Significant Companies of Clinical Laboratory Table 24. Significant Companies of Academic Institution Table 25. Significant Companies of Others Table 26. Global Optical Genome Mapping Technology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Optical Genome Mapping Technology Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Optical Genome Mapping Technology Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Optical Genome Mapping Technology Sales Value Share by Application (2021-2026) Table 30. Global Optical Genome Mapping Technology Sales Value Share by Application (2027-2032) Table 31. Global Optical Genome Mapping Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Optical Genome Mapping Technology Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Optical Genome Mapping Technology Sales Value Share by Region (2021-2026) Table 34. Global Optical Genome Mapping Technology Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Optical Genome Mapping Technology Sales Value Share by Region (2027-2032) Table 36. Global Optical Genome Mapping Technology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Optical Genome Mapping Technology Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Optical Genome Mapping Technology Sales Value Market Share by Country (2021-2026) Table 39. Global Optical Genome Mapping Technology Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Optical Genome Mapping Technology Sales Value Market Share by Country (2027-2032) Table 41. Bionano Genomics Company Information Table 42. Bionano Genomics Business Overview Table 43. Bionano Genomics Optical Genome Mapping Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Bionano Genomics Optical Genome Mapping Technology Product Portfolio Table 45. Bionano Genomics Recent Development Table 46. PerkinElmer Company Information Table 47. PerkinElmer Business Overview Table 48. PerkinElmer Optical Genome Mapping Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. PerkinElmer Optical Genome Mapping Technology Product Portfolio Table 50. PerkinElmer Recent Development Table 51. Nabsys Company Information Table 52. Nabsys Business Overview Table 53. Nabsys Optical Genome Mapping Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Nabsys Optical Genome Mapping Technology Product Portfolio Table 55. Nabsys Recent Development Table 56. Praxis Genomics Company Information Table 57. Praxis Genomics Business Overview Table 58. Praxis Genomics Optical Genome Mapping Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Praxis Genomics Optical Genome Mapping Technology Product Portfolio Table 60. Praxis Genomics Recent Development Table 61. France Génomique Company Information Table 62. France Génomique Business Overview Table 63. France Génomique Optical Genome Mapping Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. France Génomique Optical Genome Mapping Technology Product Portfolio Table 65. France Génomique Recent Development Table 66. Nucleome Informatics Company Information Table 67. Nucleome Informatics Business Overview Table 68. Nucleome Informatics Optical Genome Mapping Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Nucleome Informatics Optical Genome Mapping Technology Product Portfolio Table 70. Nucleome Informatics Recent Development Table 71. OpGen Company Information Table 72. OpGen Business Overview Table 73. OpGen Optical Genome Mapping Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. OpGen Optical Genome Mapping Technology Product Portfolio Table 75. OpGen Recent Development Table 76. Research Programs/Design for This Report Table 77. Authors List of This Report Table 78. Secondary Sources Table 79. Primary Sources List of Figures Figure 1. Optical Genome Mapping Technology Product Image Figure 2. Global Optical Genome Mapping Technology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Optical Genome Mapping Technology Market Size (2021-2032) & (US$ Million) Figure 4. Global Optical Genome Mapping Technology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Instrument Image Figure 8. System Image Figure 9. Service Image Figure 10. Global Optical Genome Mapping Technology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Optical Genome Mapping Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Optical Genome Mapping Technology Sales Value Share by Type (2021-2032) Figure 13. Biotechnology and Pharmaceutical Companies Image Figure 14. Clinical Laboratory Image Figure 15. Academic Institution Image Figure 16. Others Image Figure 17. Global Optical Genome Mapping Technology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Optical Genome Mapping Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Optical Genome Mapping Technology Sales Value Share by Application (2021-2032) Figure 20. Global Optical Genome Mapping Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Optical Genome Mapping Technology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Optical Genome Mapping Technology Sales Value (2021-2032) & (US$ Million) Figure 23. North America Optical Genome Mapping Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Optical Genome Mapping Technology Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Optical Genome Mapping Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Optical Genome Mapping Technology Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Optical Genome Mapping Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Optical Genome Mapping Technology Sales Value (2021-2032) & (US$ Million) Figure 29. South America Optical Genome Mapping Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Optical Genome Mapping Technology Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Optical Genome Mapping Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Instrument
  • System
  • Service
Applications
  • Biotechnology and Pharmaceutical Companies
  • Clinical Laboratory
  • Academic Institution
  • Others
Companies covered
  • Bionano Genomics
  • PerkinElmer
  • Nabsys
  • Praxis Genomics
  • France Génomique
  • Nucleome Informatics
  • OpGen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Optical Genome Mapping Technology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Optical Genome Mapping Technology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Optical Genome Mapping Technology Market Dynamics
  1. 2.1 Optical Genome Mapping Technology Industry Trends
  2. 2.2 Optical Genome Mapping Technology Industry Drivers
  3. 2.3 Optical Genome Mapping Technology Industry Opportunities and Challenges
  4. 2.4 Optical Genome Mapping Technology Industry Restraints
3 Optical Genome Mapping Technology Market by Company
  1. 3.1 Global Optical Genome Mapping Technology Company Revenue Ranking in 2025
  2. 3.2 Global Optical Genome Mapping Technology Revenue by Company (2021-2026)
  3. 3.3 Global Optical Genome Mapping Technology Company Ranking (2024-2026)
  4. 3.4 Global Optical Genome Mapping Technology Company Manufacturing Base and Headquarters
  5. 3.5 Global Optical Genome Mapping Technology Company Product Type and Application
  6. 3.6 Global Optical Genome Mapping Technology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Optical Genome Mapping Technology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Optical Genome Mapping Technology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Optical Genome Mapping Technology Market by Type
  1. 4.1 Optical Genome Mapping Technology Type Introduction
  2. 4.1.1 Instrument
  3. 4.1.2 System
  4. 4.1.3 Service
  5. 4.2 Global Optical Genome Mapping Technology Sales Value by Type
  6. 4.2.1 Global Optical Genome Mapping Technology Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Optical Genome Mapping Technology Sales Value by Type (2021-2032)
  8. 4.2.3 Global Optical Genome Mapping Technology Sales Value Share by Type (2021-2032)
5 Optical Genome Mapping Technology Market by Application
  1. 5.1 Optical Genome Mapping Technology Application Introduction
  2. 5.1.1 Biotechnology and Pharmaceutical Companies
  3. 5.1.2 Clinical Laboratory
  4. 5.1.3 Academic Institution
  5. 5.1.4 Others
  6. 5.2 Global Optical Genome Mapping Technology Sales Value by Application
  7. 5.2.1 Global Optical Genome Mapping Technology Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Optical Genome Mapping Technology Sales Value by Application (2021-2032)
  9. 5.2.3 Global Optical Genome Mapping Technology Sales Value Share by Application (2021-2032)
6 Optical Genome Mapping Technology Regional Value Analysis
  1. 6.1 Global Optical Genome Mapping Technology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Optical Genome Mapping Technology Sales Value by Region (2021-2032)
  3. 6.2.1 Global Optical Genome Mapping Technology Sales Value by Region: 2021-2026
  4. 6.2.2 Global Optical Genome Mapping Technology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Optical Genome Mapping Technology Sales Value (2021-2032)
  7. 6.3.2 North America Optical Genome Mapping Technology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Optical Genome Mapping Technology Sales Value (2021-2032)
  10. 6.4.2 Europe Optical Genome Mapping Technology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Optical Genome Mapping Technology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Optical Genome Mapping Technology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Optical Genome Mapping Technology Sales Value (2021-2032)
  16. 6.6.2 South America Optical Genome Mapping Technology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Optical Genome Mapping Technology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Optical Genome Mapping Technology Sales Value Share by Country, 2025 VS 2032
7 Optical Genome Mapping Technology Country-level Value Analysis
  1. 7.1 Global Optical Genome Mapping Technology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Optical Genome Mapping Technology Sales Value by Country (2021-2032)
  3. 7.2.1 Global Optical Genome Mapping Technology Sales Value by Country (2021-2026)
  4. 7.2.2 Global Optical Genome Mapping Technology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Optical Genome Mapping Technology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Optical Genome Mapping Technology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Optical Genome Mapping Technology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bionano Genomics
  2. 8.1.1 Bionano Genomics Company Information
  3. 8.1.2 Bionano Genomics Business Overview
  4. 8.1.3 Bionano Genomics Optical Genome Mapping Technology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bionano Genomics Optical Genome Mapping Technology Product Portfolio
  6. 8.1.5 Bionano Genomics Recent Developments
  7. 8.2 PerkinElmer
  8. 8.2.1 PerkinElmer Company Information
  9. 8.2.2 PerkinElmer Business Overview
  10. 8.2.3 PerkinElmer Optical Genome Mapping Technology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PerkinElmer Optical Genome Mapping Technology Product Portfolio
  12. 8.2.5 PerkinElmer Recent Developments
  13. 8.3 Nabsys
  14. 8.3.1 Nabsys Company Information
  15. 8.3.2 Nabsys Business Overview
  16. 8.3.3 Nabsys Optical Genome Mapping Technology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nabsys Optical Genome Mapping Technology Product Portfolio
  18. 8.3.5 Nabsys Recent Developments
  19. 8.4 Praxis Genomics
  20. 8.4.1 Praxis Genomics Company Information
  21. 8.4.2 Praxis Genomics Business Overview
  22. 8.4.3 Praxis Genomics Optical Genome Mapping Technology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Praxis Genomics Optical Genome Mapping Technology Product Portfolio
  24. 8.4.5 Praxis Genomics Recent Developments
  25. 8.5 France Génomique
  26. 8.5.1 France Génomique Company Information
  27. 8.5.2 France Génomique Business Overview
  28. 8.5.3 France Génomique Optical Genome Mapping Technology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 France Génomique Optical Genome Mapping Technology Product Portfolio
  30. 8.5.5 France Génomique Recent Developments
  31. 8.6 Nucleome Informatics
  32. 8.6.1 Nucleome Informatics Company Information
  33. 8.6.2 Nucleome Informatics Business Overview
  34. 8.6.3 Nucleome Informatics Optical Genome Mapping Technology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nucleome Informatics Optical Genome Mapping Technology Product Portfolio
  36. 8.6.5 Nucleome Informatics Recent Developments
  37. 8.7 OpGen
  38. 8.7.1 OpGen Company Information
  39. 8.7.2 OpGen Business Overview
  40. 8.7.3 OpGen Optical Genome Mapping Technology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 OpGen Optical Genome Mapping Technology Product Portfolio
  42. 8.7.5 OpGen Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst